信达生物高额出海催化，创新药ETF涨1.20%

财闻02-10

截至2月10日10点20分，上证指数涨0.24%，深证成指涨0.24%，创业板指涨0.23%。影视院线、知识产权保护、文化传媒等板块涨幅居前。ETF方面，创新药ETF（159992）涨1.20%，成分股信立泰（002294.SZ）、荣昌生物（688331.SH）涨超5%，海思科（002653.SZ）、泽璟制药-U（688266.SH）、药明康德（603259.SH）、迪哲医药-U（688192....

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2610972836?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-02-10 10:54","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2610972836","market":"hk","top_or_hot":-1,"title":"信达生物高额出海催化，创新药ETF涨1.20%","media":"财闻","content":"<div>\n<p>截至2月10日10点20分，上证指数涨0.24%，深证成指涨0.24%，创业板指涨0.23%。影视院线、知识产权保护、文化传媒等板块涨幅居前。ETF方面，创新药ETF（159992）涨1.20%，成分股信立泰（002294.SZ）、荣昌生物（688331.SH）涨超5%，海思科（002653.SZ）、泽璟制药-U（688266.SH）、药明康德（603259.SH）、迪哲医药-U（688192....</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210105719a6e87cb8&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>信达生物高额出海催化，创新药ETF涨1.20%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n信达生物高额出海催化，创新药ETF涨1.20%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-10 10:54 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210105719a6e87cb8&s=b><strong>财闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>截至2月10日10点20分，上证指数涨0.24%，深证成指涨0.24%，创业板指涨0.23%。影视院线、知识产权保护、文化传媒等板块涨幅居前。ETF方面，创新药ETF（159992）涨1.20%，成分股信立泰（002294.SZ）、荣昌生物（688331.SH）涨超5%，海思科（002653.SZ）、泽璟制药-U（688266.SH）、药明康德（603259.SH）、迪哲医药-U（688192....</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210105719a6e87cb8&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2488822045.USD","symbol_name":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210105719a6e87cb8&s=b","article_id":"2610972836","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210105719a6e87cb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2610972836","pubTimestamp":1770692054,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"截至2月10日10点20分，上证指数涨0.24%，深证成指涨0.24%，创业板指涨0.23%。影视院线、知识产权保护、文化传媒等板块涨幅居前。消息上，信达生物与礼来公司达成一项总付款高达88.5亿美元的全球战略合作，这是近期中国创新药企达成的高额海外授权交易。这一事件进一步验证了中国创新药企的研发实力与国际竞争力，是创新药板块出海逻辑的重要催化。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","LU0502904849.HKD":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (HKD) ACC","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","LU2097828631.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC","BK1161":"生物科技","LU2097828805.USD":"AZ EQUITY CHINA \"A-AZ\" (USD) ACC","LU0455707207.USD":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (USD) INC","BK1583":"高瓴概念","LU2097828714.EUR":"AZ EQUITY CHINA \"BAZ\" (EUR) ACC","LU2097828474.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC A","LU2097828557.USD":"AZ EQUITY CHINA \"A\" (USD) ACC","BK1589":"北水核心资产","HK0000165453.HKD":"华夏精选大中华科技基金 A类港币","01801":"信达生物"},"translate_title":"Innovent Biologics' high overseas catalysis, innovative drug ETF rose 1.20%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01801":1.5},"content_text":"截至2月10日10点20分，上证指数涨0.24%，深证成指涨0.24%，创业板指涨0.23%。影视院线、知识产权保护、文化传媒等板块涨幅居前。ETF方面，创新药ETF（159992）涨1.20%，成分股信立泰（002294.SZ）、荣昌生物（688331.SH）涨超5%，海思科（002653.SZ）、泽璟制药-U（688266.SH）、药明康德（603259.SH）、迪哲医药-U（688192.SH）、百利天恒（688506.SH）、百济神州-U（688235.SH）、凯莱英（002821.SZ）、博瑞医药（688166.SH）等上涨。消息上，信达生物与礼来公司达成一项总付款高达88.5亿美元的全球战略合作，这是近期中国创新药企达成的高额海外授权交易。这一事件进一步验证了中国创新药企的研发实力与国际竞争力，是创新药板块出海逻辑的重要催化。东海证券表示，近期圣因生物与基因泰克达成总额高达17亿美元的全球合作，印证国内小核酸前沿企业具备充分的出海技术实力；诺华Leqvio（siRNA降脂药）2025年实现营收11.98亿美元，同比增长59%，验证小核酸药物大适应症商业化可行性。小核酸赛道的高景气度持续延续，从罕见病向慢病领域加速渗透，市场规模持续扩容；跨国药企布局意愿提升，国内本土企业技术获国际认可，出海路径清晰，供应链优势凸显，板块投资价值持续提升。光大证券表示，随着国内外宏观和政策形势的变化，我们认为未来医药板块的投资应当越来越着重于医药的临床价值本质逻辑，即解决医患的临床需求。无论是国内的医保政策，还是出海的全球布局，均对于临床价值赋予越来越高的溢价。湘财证券表示，现阶段部分高值耗材企业实现业绩反转，未来业绩持续修复确定性高。近期部分高值耗材企业创新产品研发审批获得重要进展，其创新产品的获批及海外业务发展有望为公司带来集采外业绩的新增长点。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2610972836","isCrawlerRequest":true}